These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2091 related articles for article (PubMed ID: 32394467)
1. A global treatments for coronaviruses including COVID-19. Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467 [TBL] [Abstract][Full Text] [Related]
2. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Martinez MA Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082 [TBL] [Abstract][Full Text] [Related]
3. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2. Uzunova K; Filipova E; Pavlova V; Vekov T Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965 [TBL] [Abstract][Full Text] [Related]
4. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option. Yao TT; Qian JD; Zhu WY; Wang Y; Wang GQ J Med Virol; 2020 Jun; 92(6):556-563. PubMed ID: 32104907 [TBL] [Abstract][Full Text] [Related]
5. [Potential antiviral therapeutics for 2019 Novel Coronavirus]. Li H; Wang YM; Xu JY; Cao B Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):170-172. PubMed ID: 32164080 [TBL] [Abstract][Full Text] [Related]
6. Treatment options for COVID-19: The reality and challenges. Jean SS; Lee PI; Hsueh PR J Microbiol Immunol Infect; 2020 Jun; 53(3):436-443. PubMed ID: 32307245 [TBL] [Abstract][Full Text] [Related]
9. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221 [TBL] [Abstract][Full Text] [Related]
10. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817 [TBL] [Abstract][Full Text] [Related]
11. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849 [TBL] [Abstract][Full Text] [Related]
14. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics. Wang D; Li Z; Liu Y J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351 [TBL] [Abstract][Full Text] [Related]
15. The broad-spectrum antiviral recommendations for drug discovery against COVID-19. Hazafa A; Ur-Rahman K; Haq IU; Jahan N; Mumtaz M; Farman M; Naeem H; Abbas F; Naeem M; Sadiqa S; Bano S Drug Metab Rev; 2020 Aug; 52(3):408-424. PubMed ID: 32546018 [TBL] [Abstract][Full Text] [Related]
16. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2. Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective. Hosoki K; Chakraborty A; Sur S J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257 [TBL] [Abstract][Full Text] [Related]
18. Clinical Trials of Repurposed Antivirals for SARS-CoV-2. Martinez MA Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826 [TBL] [Abstract][Full Text] [Related]
19. Candidate drugs against SARS-CoV-2 and COVID-19. McKee DL; Sternberg A; Stange U; Laufer S; Naujokat C Pharmacol Res; 2020 Jul; 157():104859. PubMed ID: 32360480 [TBL] [Abstract][Full Text] [Related]
20. A Review of SARS-CoV-2 and the Ongoing Clinical Trials. Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]